Tirzepatide has emerged as a groundbreaking medication for type 2 diabetes, offering promising effects. However, the expense of this innovative drug and its supply have become key topics for patients and healthcare practitioners. While tirzepatide has been authorized by regulatory agencies, its costly nature presents a significant obstacle to many